Epigenetic Regulation of the INK4b-ARF-INK4a Locus: in Sickness and in Health
Overview
Authors
Affiliations
The INK4b-ARF-INK4a locus encodes for two cyclin-dependent kinase inhibitors, p15(INK4b) and p16(INK4a) and a regulator of the p53 pathway, ARF. In addition ANRIL, a non-coding RNA, is also transcribed from the locus. ARF, p15(INK4b) and p16(INK4a) are well-established tumor suppressors which function is frequently disabled in human cancers. Recent studies showed that single nucleotide polymorphisms mapping in the vicinity of ANRIL are linked to a wide spectrum of conditions, including cardiovascular disease, ischemic stroke, type 2 diabetes, frailty and Alzheimer's disease. The INK4b-ARF-INK4a locus is regulated by Polycomb repressive complexes (PRCs), and its expression can be invoked by activating signals. Other epigenetic modifiers such as the histone demethylases JMJD3 and JHDM1B, the SWI/SNF chromatin remodeling complex and DNA methyltransferases regulate the locus interplaying with PRCs. In view of the intimate involvement of the INK4b-ARF-INK4a locus on disease, to understand its regulation is the first step for manipulate it to therapeutic benefit.
The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer.
Balaraman A, Afzal M, Moglad E, Babu M, Priya G, Bansal P Biogerontology. 2025; 26(2):50.
PMID: 39907830 DOI: 10.1007/s10522-025-10194-2.
Cell-type specific epigenetic clocks to quantify biological age at cell-type resolution.
Tong H, Guo X, Jacques M, Luo Q, Eynon N, Teschendorff A Aging (Albany NY). 2025; 16(22):13452-13504.
PMID: 39760516 PMC: 11723652. DOI: 10.18632/aging.206184.
Epigenetics and ultraviolet radiation: Implications for skin ageing and carcinogenesis.
Barnes B, Shyne A, Gunn D, Griffiths C, Watson R Skin Health Dis. 2024; 4(6):e410.
PMID: 39624739 PMC: 11608893. DOI: 10.1002/ski2.410.
SH-SY5Y human neuronal cells with mutations of the gene are vulnerable under cultured conditions.
Ohno-Oishi M, Meiai Z, Sato K, Kanno S, Kawano C, Ishikawa M Biochem Biophys Rep. 2024; 38:101723.
PMID: 38737728 PMC: 11088231. DOI: 10.1016/j.bbrep.2024.101723.
Genomic alterations and diagnosis of renal cancer.
Zhang X, Bolck H, Rupp N, Moch H Virchows Arch. 2023; 484(2):323-337.
PMID: 37999735 PMC: 10948545. DOI: 10.1007/s00428-023-03700-9.